BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan N, Patel D, Shah Y, Trivedi C, Yang YX. Albumin as a prognostic marker for ulcerative colitis. World J Gastroenterol 2017; 23(45): 8008-8016 [PMID: 29259376 DOI: 10.3748/wjg.v23.i45.8008] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dybska E, Nowak JK, Banaszkiewicz A, Szaflarska-popławska A, Kierkuś J, Kwiecień J, Grzybowska-chlebowczyk U, Walkowiak J. Methylation of RUNX3 Promoter 2 in the Whole Blood of Children with Ulcerative Colitis. Genes 2022;13:1568. [DOI: 10.3390/genes13091568] [Reference Citation Analysis]
2 Pravda J. Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide. World J Gastroenterol 2022; 28(31): 4263-4298 [DOI: 10.3748/wjg.v28.i31.4263] [Reference Citation Analysis]
3 Winogrodzki T, Metwaly A, Grodziecki A, Liang W, Klinger B, Flisikowski K, Flisikowska T, Fischer K, Steiger K, Haller D, Schnieke A. A translational swine model for Crohn’s disease.. [DOI: 10.1101/2022.07.08.499360] [Reference Citation Analysis]
4 Chuck W, Shadbolt BF, Nordin F, Subramaniam K. BMI is important in predicting the loss of response in inflammatory bowel disease patients on tumour necrosis factor-α inhibitors. Eur J Gastroenterol Hepatol 2022;34:622-9. [PMID: 35352694 DOI: 10.1097/MEG.0000000000002371] [Reference Citation Analysis]
5 Gilca-Blanariu GE, Trifan A, Ciocoiu M, Popa IV, Burlacu A, Balan GG, Olteanu AV, Stefanescu G. Magnesium-A Potential Key Player in Inflammatory Bowel Diseases? Nutrients 2022;14:1914. [PMID: 35565881 DOI: 10.3390/nu14091914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dalal RS, McClure EL, Marcus J, Allegretti JR. Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis. Dig Dis Sci 2022. [PMID: 35415826 DOI: 10.1007/s10620-022-07472-1] [Reference Citation Analysis]
7 Truta B. Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place. World J Gastroenterol 2022; 28(13): 1380-1383 [DOI: 10.3748/wjg.v28.i13.1380] [Reference Citation Analysis]
8 Kim TH, Yeo SG, Byun JY. Role of Biomarkers as Prognostic Factors in Acute Peripheral Facial Palsy. IJMS 2021;23:307. [DOI: 10.3390/ijms23010307] [Reference Citation Analysis]
9 Zhang M, Bai X, Zhang H, You Y, Lv H, Li Y, Tan B, Li J, Xu H, Zheng W, Yang H, Qian J. The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis. Scand J Gastroenterol 2021;:1-8. [PMID: 34894997 DOI: 10.1080/00365521.2021.2006298] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lundgren D, Widbom L, Hultdin J, Karling P. Preclinical Markers in Inflammatory Bowel Disease. A Nested Case–Control Study. Crohn's & Colitis 360 2021;3:otab072. [DOI: 10.1093/crocol/otab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shang W, Hu H, Shen M, Wu J, Yu Z, Xuan L. Investigating the correlation between serum albumin level and the prognosis of Bell's palsy. Medicine (Baltimore) 2021;100:e26726. [PMID: 34398047 DOI: 10.1097/MD.0000000000026726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Matson J, Ramamoorthy S, Lopez NE. The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. J Clin Med 2021;10:3362. [PMID: 34362144 DOI: 10.3390/jcm10153362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Cristóbal JI, Duque FJ, Usón-Casaús JM, Ruiz P, Nieto EL, Pérez-Merino EM. Effects of Allogeneic Mesenchymal Stem Cell Transplantation in Dogs with Inflammatory Bowel Disease Treated with and without Corticosteroids. Animals (Basel) 2021;11:2061. [PMID: 34359189 DOI: 10.3390/ani11072061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Glapa-Nowak A, Szczepanik M, Iwańczak B, Kwiecień J, Szaflarska-Popławska AB, Grzybowska-Chlebowczyk U, Osiecki M, Dziekiewicz M, Stawarski A, Kierkuś J, Banasiewicz T, Banaszkiewicz A, Walkowiak J. Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study. World J Gastroenterol 2021; 27(14): 1483-1496 [PMID: 33911469 DOI: 10.3748/wjg.v27.i14.1483] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Yang X, Mao Z, Huang Y, Yan H, Yan Q, Hong J, Fan J, Yao J. Reductively modified albumin attenuates DSS-Induced mouse colitis through rebalancing systemic redox state. Redox Biol 2021;41:101881. [PMID: 33601276 DOI: 10.1016/j.redox.2021.101881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
16 Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 2021;160:1452-1460.e21. [PMID: 33421515 DOI: 10.1053/j.gastro.2020.10.065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
17 Kaur P, Attard TM, Fishman DS, Zapata F, Ditsch D, Thomson M, Schurman JV. A Conceptual Framework for Rescheduling Elective Pediatric Gastroenterology Procedures Following COVID-19 Pandemic Lockdown. Gastroenterol Nurs 2020;43:375-81. [PMID: 33003024 DOI: 10.1097/SGA.0000000000000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kaenkumchorn T, Wahbeh G. Ulcerative Colitis: Making the Diagnosis. Gastroenterol Clin North Am 2020;49:655-69. [PMID: 33121687 DOI: 10.1016/j.gtc.2020.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
19 Bai M, Wu Y, Ji Z, Wang S, Lin Z, Pan S, Huang K. Prognostic value of C-reactive protein/albumin ratio in neurocritically ill patients. Minerva Anestesiol 2019;85:1299-307. [PMID: 31486619 DOI: 10.23736/S0375-9393.19.13625-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Nishida Y, Hosomi S, Yamagami H, Sugita N, Itani S, Yukawa T, Otani K, Nagami Y, Tanaka F, Taira K, Kamata N, Kakimoto K, Tanigawa T, Watanabe T, Fujiwara Y. Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis. Intern Med 2019;58:2305-2313. [DOI: 10.2169/internalmedicine.2632-19] [Reference Citation Analysis]
21 Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220-246. [PMID: 31352652 DOI: 10.1007/s12664-019-00976-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]